KOUTERLOS
0450.036.349 · rovalta.com · 21/09/2026
KOUTERLOS
Overview
What does KOUTERLOS do?
KOUTERLOS is a Public limited company incorporated in 1993. Its main activity is: Operation of sports facilities. Its registered office is in Gent.
9051 Gent · FlandreSee on map
Trend over 18 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 55,3 k € | -5.5% | 58,5 k € | -6.0% | 62,3 k € | +47.5% | 42,2 k € | -5.4% | 44,6 k € | -3.5% | 46,3 k € | +60.2% | 28,9 k € | +33.0% | 21,7 k € | -36.8% | 34,4 k € | -19.6% | 42,7 k € | +9.5% | 39 k € | -61.0% | 100 k € | +285% | 26 k € | +7.9% | 24,1 k € | +2.4% | 23,5 k € | -6.2% | 25,1 k € | +19.2% | 21 k € | +3.7% | 20,3 k € |
| EBITDA | 50,6 k € | -5.3% | 53,5 k € | -7.9% | 58 k € | +82.0% | 31,9 k € | -19.5% | 39,6 k € | -7.6% | 42,9 k € | +87.1% | 22,9 k € | +20.8% | 19 k € | -41.8% | 32,6 k € | -20.4% | 41 k € | +8.5% | 37,8 k € | -61.8% | 98,8 k € | +300% | 24,7 k € | +7.5% | 23 k € | +2.5% | 22,4 k € | -6.6% | 24 k € | +22.0% | 19,7 k € | +2.5% | 19,2 k € |
| Operating result | 30,3 k € | -8.1% | 33 k € | -8.7% | 36,1 k € | +136% | 15,3 k € | -36.4% | 24 k € | -11.9% | 27,3 k € | +52255% | -52,3 € | -100% | 13,7 k € | -7.3% | 14,7 k € | -28.9% | 20,7 k € | +32.2% | 15,7 k € | -73.5% | 59,1 k € | +5702% | -1,1 k € | -107% | 14,9 k € | +3.9% | 14,4 k € | -10.0% | 16 k € | +37.1% | 11,7 k € | -3.1% | 12 k € |
| Net result | 18,6 k € | +4.2% | 17,9 k € | -14.1% | 20,8 k € | +252% | 5,9 k € | -62.1% | 15,6 k € | -13.1% | 18 k € | +319% | -8,2 k € | -241% | 5,8 k € | -21.6% | 7,4 k € | +411% | 1,4 k € | +114% | -10,1 k € | -132% | 31,9 k € | +466% | -8,7 k € | -195% | 9,2 k € | +9.3% | 8,4 k € | -12.4% | 9,6 k € | +94.9% | 4,9 k € | -1.2% | 5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 321,3 k € | +6.2% | 302,6 k € | +6.3% | 284,8 k € | +7.9% | 264 k € | +2.3% | 258 k € | +6.4% | 242,4 k € | +8.0% | 224,5 k € | -3.5% | 232,7 k € | +4.1% | 223,5 k € | +3.4% | 216,1 k € | +0.7% | 214,7 k € | -4.5% | 224,7 k € | +16.6% | 192,8 k € | -4.3% | 201,5 k € | +4.8% | 192,3 k € | +4.6% | 183,9 k € | +5.5% | 174,3 k € | +2.9% | 169,3 k € |
| Total assets | 766 k € | -1.9% | 781,1 k € | -2.6% | 801,8 k € | -7.6% | 867,9 k € | +11.2% | 780,5 k € | -0.7% | 786,1 k € | -11.8% | 891,7 k € | +30.6% | 683 k € | -1.1% | 690,9 k € | -0.1% | 691,8 k € | -0.9% | 697,8 k € | -0.9% | 704,2 k € | +51.6% | 464,4 k € | +46.9% | 316 k € | -1.8% | 321,9 k € | -2.0% | 328,6 k € | -4.3% | 343,2 k € | -0.1% | 343,4 k € |
| Cash | 53,7 k € | +0.8% | 53,2 k € | -0.4% | 53,4 k € | +3.0% | 51,9 k € | +44.5% | 35,9 k € | +91.6% | 18,7 k € | -36.5% | 29,5 k € | -2.8% | 30,3 k € | +251% | 8,6 k € | +30.8% | 6,6 k € | -62.9% | 17,8 k € | -55.4% | 39,9 k € | +451% | 7,2 k € | -30.1% | 10,4 k € | +26.2% | 8,2 k € | +85.5% | 4,4 k € | -64.8% | 12,6 k € | +9.4% | 11,5 k € |
| Debts | 416,2 k € | -7.6% | 450,2 k € | -7.9% | 488,8 k € | -15.1% | 575,8 k € | +16.5% | 494,2 k € | -4.1% | 515,4 k € | -19.3% | 639 k € | +51.5% | 421,9 k € | -3.9% | 439,2 k € | -1.8% | 447,5 k € | -1.8% | 455,6 k € | -2.2% | 465,7 k € | +75.3% | 265,7 k € | +141% | 110,1 k € | -12.1% | 125,2 k € | -10.7% | 140,2 k € | -14.7% | 164,5 k € | -2.4% | 168,5 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/09/2024 · 4 active · 13 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
b+pharma Belgium● Active | 0474.817.869 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
Ceres Pharmaceuticals● Active | 0407.326.754 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
CREDOPHAR● Active | 0849.730.193 |
DGPharma● Active | 0508.925.544 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
Labophar● Active | 0643.723.177 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 |
| Closing of the financial year | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/04/2025 | 29/04/2024 | 25/04/2023 | 25/04/2022 | 23/04/2021 | 17/04/2020 |
| General meeting | 27/03/2025 | 30/03/2024 | 25/03/2023 | 26/03/2022 | 27/03/2021 | 28/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2024 | 27/03/2025 | 17/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 30/03/2024 | 29/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 25/03/2023 | 25/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 26/03/2022 | 25/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 27/03/2021 | 23/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 28/03/2020 | 17/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 30/03/2019 | 30/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 31/03/2018 | 20/04/2018 | Dutch | |
| Abridged model | 30/09/2016 | 25/03/2017 | 25/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 26/03/2016 | 27/04/2016 | Dutch | |
| Abridged model | 30/09/2014 | 28/03/2015 | 24/04/2015 | Dutch | |
| Abridged model | 30/09/2013 | 29/03/2014 | 28/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 30/03/2013 | 26/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 31/03/2012 | 26/04/2012 | Dutch | |
| Abridged model | 30/09/2010 | 26/03/2011 | 21/04/2011 | Dutch | |
| Abridged model | 30/09/2009 | 27/03/2010 | 23/04/2010 | Dutch | |
| Abridged model | 30/09/2008 | 28/03/2009 | 30/04/2009 | Dutch | |
| Abridged model | 30/09/2007 | 29/03/2008 | 31/03/2008 | Dutch | |
| Abridged model | 30/09/2006 | 31/03/2007 | 24/04/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/09/2024 · 4 active · 13 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other04/07/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING - BOEKJAAR
- Mandates18/04/2025MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates07/05/2024ONTSLAGEN - BENOEMINGEN
- Mandates07/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates19/05/2023MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates12/04/2017ONTSLAGEN - BENOEMINGEN
- Mandates14/04/2011ONTSLAGEN - BENOEMINGEN
- Mandates24/01/2007ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202418,6 k €↑
- 2023Annual accounts 202317,9 k €↓
- 2022Annual accounts 202220,8 k €↑
- 2021Annual accounts 20215,9 k €↓
- 2020Annual accounts 202015,6 k €↓
- 2019Annual accounts 201918 k €↑
- 2018Annual accounts 2018-8,2 k €↓
- 2017Annual accounts 20175,8 k €↓
- 2015Annual accounts 20157,4 k €↑
- 2014Annual accounts 20141,4 k €↑
- 2013Annual accounts 2013-10,1 k €↓
- 2012Annual accounts 201231,9 k €↑
- 2011Annual accounts 2011-8,7 k €↓
- 2010Annual accounts 20109,2 k €↑
- 2009Annual accounts 20098,4 k €↓
- 2008Annual accounts 20089,6 k €↑
- 2007Annual accounts 20074,9 k €↓
- 2006Annual accounts 20065 k €
- 30/04/1993IncorporationPublic limited company